BMY
Price
$63.64
Change
-$0.11 (-0.17%)
Updated
Sep 11 closing price
Capitalization
130B
46 days until earnings call
Intraday BUY SELL Signals
XLV
Price
$165.36
Change
-$0.30 (-0.18%)
Updated
Sep 11 closing price
Net Assets
43.09B
Intraday BUY SELL Signals
Interact to see
Advertisement

BMY vs XLV

BMY vs XLV Comparison Chart in %
View a ticker or compare two or three
VS
BMY vs. XLV commentary
Sep 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a Buy and XLV is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BMY: Fundamental Ratings
BMY
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMYXLV
RSI
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
45%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
57%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
84%
COMPARISON
Comparison
Sep 14, 2026
Stock price -- (BMY: $63.64)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 1 FA rating(s) are green while .

  • BMY’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 4 TA indicator(s) are bullish.

  • BMY’s TA Score: 4 bullish, 4 bearish.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а -4.76% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -4.36%. For the same industry, the average monthly price growth was -3.99%, and the average quarterly price growth was +5.78%.

Reported Earning Dates

BMY is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-4.36% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
BMY
Daily Signal:
Gain/Loss:
XLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMFG27.290.74
+2.79%
Sumitomo Mitsui Financial Group
RIG5.67-0.10
-1.73%
Transocean Ltd
GTEC1.05-0.02
-1.87%
Greenland Technologies Holding Corp
INR14.92-0.46
-2.99%
Infinity Natural Resources Inc
KMTS22.85-0.72
-3.05%
Kestra Medical Technologies, Ltd.

XLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLV
1D Price
Change %
XLV100%
-0.18%
LLY - XLV
73%
Closely correlated
-0.65%
MRK - XLV
69%
Closely correlated
-0.54%
ABBV - XLV
63%
Loosely correlated
+0.83%
JNJ - XLV
61%
Loosely correlated
-0.29%
BMY - XLV
61%
Loosely correlated
-0.17%
More